Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 56
Filter
4.
Sci Rep ; 7: 46557, 2017 04 24.
Article in English | MEDLINE | ID: mdl-28436427

ABSTRACT

Broadly Cross clade Neutralizing (BCN) antibodies are recognized as potential therapeutic tools and leads for the design of a vaccine that can protect human beings against various clades of Human Immunodeficiency Virus (HIV). In the present study, we screened plasma of 88 HIV-1 infected ART naïve individuals for their neutralization potential using a standard panel of 18 pseudoviruses belonging to different subtypes and different levels of neutralization. We identified 12 samples with good breadth of neutralization (neutralized >90% of the viruses). Four of these samples neutralized even the difficult-to-neutralize tier-3 pseudoviruses with great potency (GMT > 600). Analysis of neutralization specificities indicated that four samples had antibodies with multiple epitope binding specificities, viz. CD4-binding site (CD4BS), glycans in the V1/V2 and V3 regions and membrane proximal external region (MPER). Our findings indicate the strong possibility of identifying highly potent bNAbs with known or novel specificities from HIV-1 subtype C infected individuals from India that can be exploited as therapeutic tools or lead molecules for the identification of potential epitopes for design of a protective HIV-1 vaccine.


Subject(s)
Antibodies, Neutralizing/immunology , Antibody Specificity , HIV Antibodies/immunology , HIV Infections/immunology , HIV-1/immunology , Adult , Female , Humans , Male , Middle Aged
5.
Am J Med Sci ; 348(1): 57-64, 2014 Jul.
Article in English | MEDLINE | ID: mdl-24374737

ABSTRACT

An immunoepidemiological study was performed to evaluate the effect of neonatal bacillus Calmette-Guérin (BCG) vaccination and tuberculin response on macrophage killing profile against Mycobacterium tuberculosis. In this epidemiological field work, the study subjects were drawn from in and around Chennai city, South India. The descriptive epidemiological pattern of neonatal BCG vaccination and its impact on tuberculin skin test were studied. The study subjects for the immunologic laboratory experiments were recruited based on the skin test (Mantoux) outcome and were grouped in to 4 natural study groups that include vaccinated reactors, vaccinated nonreactors, nonvaccinated reactors and nonvaccinated nonreactors. In immunologic laboratory work part, the elucidation of macrophage killing profile was studied for all the 4 groups, and appropriate intercomparisons were made. The parameters used for the macrophage killing profile were (1) glutathione assay, (2) measurement of phagocytosis, (3) intracellular growth kinetics of M. tuberculosis H37Rv, (4) tumor necrosis factor-α assay and (5) interferon-γ assay. The results found that in the BCG-vaccinated tuberculin reactors the macrophage responses were significantly higher than the BCG-vaccinated tuberculin nonreactors. There was no significant difference in the responses among the BCG-vaccinated tuberculin reactors when compared with the nonvaccinated tuberculin reactors. The immune responses of nonvaccinated tuberculin reactors were significantly higher than the vaccinated tuberculin nonreactors. These findings show that the immune response among the adolescents/young adults is elicited by exposure to mycobacteria and not by the neonatal BCG vaccination.


Subject(s)
BCG Vaccine/therapeutic use , Environmental Exposure/prevention & control , Macrophages/immunology , Mycobacterium bovis/isolation & purification , Tuberculosis/prevention & control , Vaccination/trends , Adolescent , BCG Vaccine/immunology , Cells, Cultured , Cross-Sectional Studies , Humans , Immunity, Cellular , India/epidemiology , Infant, Newborn , Macrophages/microbiology , Male , Mycobacterium bovis/immunology , Tuberculosis/epidemiology , Tuberculosis/immunology , Young Adult
6.
AIDS Res Hum Retroviruses ; 29(1): 47-53, 2013 Jan.
Article in English | MEDLINE | ID: mdl-22924625

ABSTRACT

HLA-B*27:05 is one of the widely reported alleles associated with resistance to HIV, while HLA-A24, HLA-B7, HLA-B*07:02, HLA-B*35:01, HLA-B*53:01, and HLA-B40 are reported to be associated with susceptibility to HIV. Using a bioinformatics approach we attempted to predict potential HLA-B*27:05-specific HIV-1C epitopes that do not bind to susceptibility-associated HLA alleles based on our hypothesis that such epitopes have a greater probability of eliciting a protective immune response in the host. A consensus sequence was built for all proteins of Indian clade C virus. Epitopes specific to HLA-B*27:05 were predicted from the consensus sequence using two different bioinformatics methods to enhance the accuracy of the prediction. Epitopes that were also predicted to bind to any of the susceptibility-associated HLA alleles were excluded from the list. The short-listed epitopes were modeled using MODPROPEP to refine the prediction. Fourteen peptides were identified as epitopes by both sequence-based methods and were found to interact strongly with HLA-B*27:05 by molecular modeling studies. Five of the 14 epitopes were previously reported as immunogenic by other researchers, while the remaining nine are novel. The 14 epitopes have been repeatedly identified by three different methods indicating their potential as useful candidates for an effective HIV vaccine.


Subject(s)
Epitopes, T-Lymphocyte/genetics , HIV-1/immunology , HLA-B27 Antigen/genetics , T-Lymphocytes, Cytotoxic/immunology , Computational Biology , Consensus Sequence/genetics , Consensus Sequence/immunology , Epitopes, T-Lymphocyte/immunology , HIV Infections/genetics , HIV Infections/immunology , HLA-B27 Antigen/immunology , Humans , Immunity, Cellular/genetics , Immunity, Cellular/physiology , India
7.
Int J Bacteriol ; 2013: 512481, 2013.
Article in English | MEDLINE | ID: mdl-26904726

ABSTRACT

Activation of the complement component C3 is an important step in the complement cascade, contributing to inflammatory mechanisms. Considerable research on gene-disrupted mycobacterial strains using animal models of tuberculosis infection has reported the roles of some of the mycobacterial genes during tuberculosis infection. The aim of the present study was to assess the pattern of complement activation by the devR gene-disrupted Mycobacterium tuberculosis H37Rv strain and compare with that by its wild-type strain. In vitro complement activation at the level of C3 by the gene-disrupted strain, its complemented strain, and wild-type strain was performed using solid-phase ELISA. It was observed that the ability of devR gene-disrupted M. tuberculosis H37Rv to activate C3 was significantly reduced in comparison to its wild-type strain (P < 0.05). In addition, C3 activation by the complemented devR mutant strain was almost similar to that of the wild strain, which indicated that the reduced ability to activate C3 could potentially be due to the deletion of devR gene. These findings indicate that the gene devR probably aids in complement activation and contributes to the inflammatory processes during tuberculosis infection.

8.
Clin Vaccine Immunol ; 19(12): 1965-71, 2012 Dec.
Article in English | MEDLINE | ID: mdl-23100480

ABSTRACT

Circulating immune complexes (ICs) are associated with the pathogenesis of several diseases. Very little is known about the effect of ICs on the host immune response in patients with tuberculosis (TB). The effects of ICs isolated from patients with TB in modulating the release of calcium, cytokines, and granular proteins were studied in normal granulocytes, as were their chemotactic, phagocytic, and oxidative burst processes. ICs from TB patients induced decreased production of cytokines and platelet-activating factor (PAF) from normal granulocytes. ICs from TB patients also induced enhanced chemotaxis and phagocytosis but caused diminished oxidative burst. This was accompanied by an increased release in intracellular calcium. On the other hand, ICs from TB patients induced increased release of the granular proteins human neutrophil peptides 1 to 3 (HNP1-3). Thus, ICs from patients with TB exhibit a profound effect on granulocyte function with activation of certain effector mechanisms and dampening of others.


Subject(s)
Antigen-Antibody Complex/immunology , Granulocytes/immunology , Tuberculosis, Pulmonary/immunology , Adult , Calcium/metabolism , Chemotaxis , Cytokines/metabolism , Female , Granulocytes/metabolism , Humans , Male , Middle Aged , Phagocytosis , Platelet Activating Factor/metabolism
9.
Indian J Exp Biol ; 50(8): 542-50, 2012 Aug.
Article in English | MEDLINE | ID: mdl-23016491

ABSTRACT

Mycobacterium tuberculosis-specific antibodies possess immunomodulatory effects during tuberculosis infection. Prior sensitization to environmental mycobacteria is known to suppress immune responses against BCG and M. tuberculosis. Mycobacteria-induced antibodies can influence events such as complement activation and phagocytosis during infectious process. In the present study role of anti-M. tuberculosis IgG (anti-M. tb IgG) antibody during interaction between M. tuberculosis and human macrophages mediated through complement has been examined in vitro. Anti-M. tb IgG antibody significantly enhanced complement activation by M. tuberculosis. Phagocytosis of M. tuberculosis by macrophages increased significantly in the presence of complement and/or antibody. Moreover, antibody enhanced phagocytosis in the presence of complement. Addition of antibody alone or in combination with complement also augmented intracellular viability of bacilli within macrophages. Results of this study showed that anti-mycobacterial antibody enhances complement activation and anti-M. tb IgG antibody probably modulates effects of complement during early stages of tuberculosis infection.


Subject(s)
Complement Activation , Host-Pathogen Interactions , Macrophages/microbiology , Mycobacterium tuberculosis/physiology , Adult , Blotting, Western , Electrophoresis, Polyacrylamide Gel , Enzyme-Linked Immunosorbent Assay , Female , Humans , Male , Middle Aged , Mycobacterium tuberculosis/growth & development
10.
PLoS One ; 7(4): e35847, 2012.
Article in English | MEDLINE | ID: mdl-22563409

ABSTRACT

BACKGROUND: The DevR(DosR) regulon is implicated in hypoxic adaptation and virulence of Mycobacterium tuberculosis. The present study was designed to decipher the impact of perturbation in DevR-mediated signaling on these properties. METHODOLOGY/PRINCIPAL FINDINGS: M. tb complemented (Comp) strains expressing different levels of DevR were constructed in Mut1* background (expressing DevR N-terminal domain in fusion with AphI (DevR(N)-Kan) and in Mut2ΔdevR background (deletion mutant). They were compared for their hypoxia adaptation and virulence properties. Diverse phenotypes were noted; basal level expression (∼5.3±2.3 µM) when induced to levels equivalent to WT levels (∼25.8±9.3 µM) was associated with robust DevR regulon induction and hypoxic adaptation (Comp 9* and 10*), whereas low-level expression (detectable at transcript level) as in Comp 11* and Comp15 was associated with an adaptation defect. Intermediate-level expression (∼3.3±1.2 µM) partially restored hypoxic adaptation functions in Comp2, but not in Comp1* bacteria that co-expressed DevR(N)-Kan. Comp* strains in Mut1* background also exhibited diverse virulence phenotypes; high/very low-level DevR expression was associated with virulence whereas intermediate-level expression was associated with low virulence. Transcription profiling and gene expression analysis revealed up-regulation of the phosphate starvation response (PSR) in Mut1* and Comp11* bacteria, but not in WT/Mut2ΔdevR/other Comp strains, indicating a plasticity in expression pathways that is determined by the magnitude of signaling perturbation through DevR(N)-Kan. CONCLUSIONS/SIGNIFICANCE: A minimum DevR concentration of ∼3.3±1.2 µM (as in Comp2 bacteria) is required to support HspX expression in the standing culture hypoxia model. The relative intracellular concentrations of DevR and DevR(N)-Kan appear to be critical for determining dormancy regulon induction, hypoxic adaptation and virulence. Dysregulated DevR(N)-Kan-mediated signaling selectively triggers the PSR in bacteria expressing no/very low level of DevR. Our findings illustrate the important role of appropriate two-component-mediated signaling in pathogen physiology and the resilience of bacteria when such signaling is perturbed.


Subject(s)
Anaerobiosis , Bacterial Proteins/metabolism , Mycobacterium tuberculosis/pathogenicity , Protein Kinases/metabolism , Animals , Antigens, Bacterial/genetics , Antigens, Bacterial/metabolism , Bacterial Proteins/genetics , DNA-Binding Proteins , Gene Expression Regulation, Bacterial , Guinea Pigs , Mycobacterium tuberculosis/metabolism , Phenotype , Protein Kinases/genetics , Signal Transduction , Transcription, Genetic , Virulence
11.
Vaccine ; 29(45): 8118-25, 2011 Oct 19.
Article in English | MEDLINE | ID: mdl-21856361

ABSTRACT

An efficient global control of tuberculosis requires development of alternative vaccination strategies that can enhance the efficacy of existing BCG vaccine. In this study, we evaluated the protective efficacy of a recombinant BCG (rBCG) vaccine over-expressing iron-cofactored superoxide dismutase (SOD-A), one of the prominent oxidative stress response proteins of Mycobacterium tuberculosis. Contrary to our expectations, over-expression of SOD-A resulted in the abrogation of BCG's ability to confer protection in guinea pig as well as in murine model. Analysis of immune responses revealed that over-expression of SOD-A by rBCG has pleiotropic effects on innate and adaptive immune responses. Macrophages infected in vitro with rBCG exhibited a marked reduction in apoptosis and microbicidal potential. In addition, rBCG vaccination of mice resulted in a reduced IFNγ and increased IL10 production when compared with the BCG vaccination. Further, we show that rBCG vaccination failed to generate an effective multi-functional CD4 T cell response. Altogether, our findings suggest that over-expression of SOD-A in BCG enhances the immuno-suppressive properties of BCG, characterized by skewing of immune responses towards Th2 type, an inefficient multi-functional T cell response and reduced apoptosis and microbicidal potential of macrophages leading to abolishment of BCG's protective efficacy.


Subject(s)
BCG Vaccine/immunology , Bacterial Proteins/biosynthesis , Gene Expression , Superoxide Dismutase/biosynthesis , Tuberculosis/prevention & control , Animals , Apoptosis , BCG Vaccine/administration & dosage , CD4-Positive T-Lymphocytes/immunology , Female , Guinea Pigs , Immunosuppression Therapy , Interferon-gamma/metabolism , Interleukin-10/metabolism , Macrophages/immunology , Mice , Mice, Inbred BALB C , Vaccines, Synthetic/administration & dosage , Vaccines, Synthetic/immunology
12.
PLoS One ; 6(8): e23360, 2011.
Article in English | MEDLINE | ID: mdl-21858087

ABSTRACT

BACKGROUND: In spite of a consistent protection against tuberculosis (TB) in children, Mycobacterium bovis Bacille Calmette-Guerin (BCG) fails to provide adequate protection against the disease in adults as well as against reactivation of latent infections or exogenous reinfections. It has been speculated that failure to generate adequate memory T cell response, elicitation of inadequate immune response against latency-associated antigens and inability to impart long-term immunity against M. tuberculosis infections are some of the key factors responsible for the limited efficiency of BCG in controlling TB. METHODS/PRINCIPAL FINDINGS: In this study, we evaluated the ability of a DNA vaccine expressing α-crystallin--a key latency antigen of M. tuberculosis to boost the BCG induced immunity. 'BCG prime-DNA boost' regimen (B/D) confers robust protection in guinea pigs along with a reduced pathology in comparison to BCG vaccination (1.37 log(10) and 1.96 log(10) fewer bacilli in lungs and spleen, respectively; p<0.01). In addition, B/D regimen also confers enhanced protection in mice. Further, we show that B/D immunization in mice results in a heightened frequency of PPD and antigen specific multi-functional CD4 T cells (3(+)) simultaneously producing interferon (IFN)γ, tumor necrosis factor (TNF)α and interleukin (IL)2. CONCLUSIONS/SIGNIFICANCE: These results clearly indicate the superiority of α-crystallin based B/D regimen over BCG. Our study, also demonstrates that protection against TB is predictable by an increased frequency of 3(+) Th1 cells with superior effector functions. We anticipate that this study would significantly contribute towards the development of superior booster vaccines for BCG vaccinated individuals. In addition, this regimen can also be expected to reduce the risk of developing active TB due to reactivation of latent infection.


Subject(s)
BCG Vaccine/immunology , Bacterial Proteins/immunology , Mycobacterium tuberculosis/immunology , Tuberculosis/immunology , Vaccines, DNA/immunology , alpha-Crystallins/immunology , Adult , Animals , BCG Vaccine/administration & dosage , Bacterial Proteins/genetics , CD4-Positive T-Lymphocytes/drug effects , CD4-Positive T-Lymphocytes/immunology , CD4-Positive T-Lymphocytes/metabolism , Drug Evaluation, Preclinical , Drug Synergism , Female , Flow Cytometry , Granuloma/immunology , Granuloma/pathology , Granuloma/prevention & control , Guinea Pigs , Humans , Immunization, Secondary/methods , Interferon-gamma/immunology , Interferon-gamma/metabolism , Kidney/drug effects , Kidney/immunology , Kidney/pathology , Lung/drug effects , Lung/immunology , Lung/pathology , Lung Diseases/immunology , Lung Diseases/pathology , Lung Diseases/prevention & control , Mice , Mice, Inbred BALB C , Mycobacterium bovis/immunology , Mycobacterium tuberculosis/genetics , Tuberculosis/prevention & control , Tumor Necrosis Factor-alpha/immunology , Tumor Necrosis Factor-alpha/metabolism , Vaccines, DNA/administration & dosage , alpha-Crystallins/genetics
13.
PLoS One ; 6(4): e18773, 2011 Apr 18.
Article in English | MEDLINE | ID: mdl-21533158

ABSTRACT

BACKGROUND: Efficient control of tuberculosis (TB) requires development of strategies that can enhance efficacy of the existing vaccine Mycobacterium bovis Bacille Calmette Guerin (BCG). To date only a few studies have explored the potential of latency-associated antigens to augment the immunogenicity of BCG. METHODS/PRINCIPAL FINDINGS: We evaluated the protective efficacy of a heterologous prime boost approach based on recombinant BCG and DNA vaccines targeting α-crystallin, a prominent latency antigen. We show that "rBCG prime-DNA boost" strategy (R/D) confers a markedly superior protection along with reduced pathology in comparison to BCG vaccination in guinea pigs (565 fold and 45 fold reduced CFU in lungs and spleen, respectively, in comparison to BCG vaccination). In addition, R/D regimen also confers enhanced protection in mice. Our results in guinea pig model show a distinct association of enhanced protection with an increased level of interleukin (IL)12 and a simultaneous increase in immuno-regulatory cytokines such as transforming growth factor (TGF)ß and IL10 in lungs. The T cell effector functions, which could not be measured in guinea pigs due to technical limitations, were characterized in mice by multi-parameter flow cytometry. We show that R/D regimen elicits a heightened multi-functional CD4 Th1 cell response leading to enhanced protection. CONCLUSIONS/SIGNIFICANCE: These results clearly indicate the superiority of α-crystallin based R/D regimen over BCG. Our observations from guinea pig studies indicate a crucial role of IL12, IL10 and TGFß in vaccine-induced protection. Further, characterization of T cell responses in mice demonstrates that protection against TB is predictable by the frequency of CD4 T cells simultaneously producing interferon (IFN)γ, tumor necrosis factor (TNF)α and IL2. We anticipate that this study will not only contribute toward the development of a superior alternative to BCG, but will also stimulate designing of TB vaccines based on latency antigens.


Subject(s)
Cytokines/metabolism , Lung/metabolism , Tuberculosis, Pulmonary/prevention & control , alpha-Crystallins/administration & dosage , Animals , BCG Vaccine/administration & dosage , Guinea Pigs , Lung/pathology , Mice , Models, Animal , Mycobacterium bovis/growth & development , Mycobacterium bovis/immunology , Tuberculosis, Pulmonary/pathology
14.
Indian J Med Res ; 131: 555-8, 2010 Apr.
Article in English | MEDLINE | ID: mdl-20424307

ABSTRACT

BACKGROUND & OBJECTIVES: Results of earlier studies to evaluate the possible role of complement system in tropical pulmonary eosinophilia (TPE) using classical methods like serum haemolyte component CH50, C3 and C4 levels were inconclusive. In this study we determined levels of serum C3d which is a catabolic fragment of C3, to find out any direct evidence of activation of the complement system in TPE. METHODS: The study population consisted of 3 groups. Group A consisted of 37 patients with well characterized TPE. In group B, 26 patients with pulmonary eosinophilia had similar respiratory and haemotological features as in Group A but had associated worm infestation in stool. The control group consisted of 39 healthy volunteers. Serum C3d levels were determined by sandwich ELISA technique. RESULTS: The serum C3d levels in TPE patients were not significantly different from those of the patients of group B or the normal controls. INTERPRETATION & CONCLUSIONS: Absence of significant change in serum C3d goes against the possibility of complement activation in TPE. Results of our study suggest that complement system is unlikely to play a pivotal role in pathogenesis of TPE.


Subject(s)
Complement C3d/metabolism , Pulmonary Eosinophilia/blood , Tropical Medicine , Adolescent , Adult , Aged , Case-Control Studies , Child , Enzyme-Linked Immunosorbent Assay , Female , Humans , Male , Middle Aged
15.
PLoS One ; 5(2): e9448, 2010 Feb 26.
Article in English | MEDLINE | ID: mdl-20195478

ABSTRACT

BACKGROUND: The DevR response regulator is implicated in both hypoxic adaptation and virulence of Mycobacterium tuberculosis (M. tb). DevR regulon genes are powerfully induced in vivo implicating them in bacterial adaptation to host control strategies. A better understanding of DevR function will illumine the way for new strategies to control and treat tuberculosis. METHODOLOGY/PRINCIPAL FINDINGS: Towards this objective, we used a combination of genetic, microbiological, biochemical, cell biological tools and a guinea pig virulence assay to compare the hypoxic adaptation and virulence properties of two novel M. tb strains, namely, a devR disruption mutant, Mut1, that expresses C-terminal truncated N-terminal domain of DevR (DevR(NTD)) as a fusion protein with AphI (DevR(N)-Kan), and its complemented strain, Comp1, that expresses intact DevR along with DevR(N)-Kan. Comp1 bacteria exhibit a defect in DevR-mediated phosphosignalling, hypoxic induction of HspX and also hypoxic survival. In addition, we find that Comp1 is attenuated in virulence in guinea pigs and shows decreased infectivity of THP-1 cells. While Mut1 bacilli are also defective in hypoxic adaptation and early growth in spleen, they exhibit an overall virulence comparable to that of wild-type bacteria. CONCLUSIONS/SIGNIFICANCE: The hypoxic defect of Comp1 is associated to a defect in DevR expression level. The demonstrated repression of DevR function by DevR(N)-Kan suggests that such a knockdown approach could be useful for evaluating the activity of DevRS and other two-component signaling pathways. Further investigation is necessary to elucidate the mechanism underlying Comp1 attenuation.


Subject(s)
Adaptation, Physiological/genetics , Bacterial Proteins/genetics , Mutation , Mycobacterium tuberculosis/genetics , Trans-Activators/genetics , Anaerobiosis , Animals , Cell Line , Gene Expression Regulation, Bacterial , Genetic Complementation Test , Guinea Pigs , Humans , Lung/microbiology , Microbial Viability/genetics , Mutant Proteins/genetics , Mycobacterium tuberculosis/pathogenicity , Mycobacterium tuberculosis/physiology , Regulon/genetics , Signal Transduction/genetics , Tuberculosis/microbiology , Virulence/genetics
16.
Vaccine ; 28(1): 63-70, 2009 Dec 10.
Article in English | MEDLINE | ID: mdl-19835824

ABSTRACT

Owing to its highly immunodominant nature and ability to induce long-lived memory immunity, ESAT-6, a prominent antigen of Mycobacterium tuberculosis, has been employed in several approaches to develop tuberculosis vaccines. Here, for the first time, we combined ESAT-6 based recombinant BCG (rBCG) and DNA vaccine (DNAE6) in a prime boost approach. Interestingly, in spite of inducing an enhanced antigen specific IFN-gamma response in mice, a DNAE6 booster completely obliterated the protection imparted by rBCG against tuberculosis in guinea pigs. Analysis of immunopathology and cytokine responses suggests involvement of an exaggerated immunity behind the lack of protection imparted by this regimen.


Subject(s)
Antigens, Bacterial/immunology , BCG Vaccine/immunology , Bacterial Proteins/immunology , Immunization, Secondary , Tuberculosis, Pulmonary/prevention & control , Animals , Female , Guinea Pigs , Interferon-gamma/immunology , Lung/immunology , Lung/microbiology , Lung/pathology , Mice , Mice, Inbred BALB C , Mycobacterium tuberculosis/immunology , Spleen/immunology , Spleen/microbiology , Spleen/pathology , Tuberculosis, Pulmonary/immunology , Vaccines, DNA/immunology
17.
J Clin Immunol ; 29(5): 674-80, 2009 Sep.
Article in English | MEDLINE | ID: mdl-19472039

ABSTRACT

INTRODUCTION: Association between inherited deficiencies of the complement components and immune complex disease indicates the importance of the complement system in the handling of circulating immune complexes. High levels of circulating immune complexes are seen in pulmonary tuberculosis. This study is, therefore, aimed to look at the concentration of circulating immune complexes, the status of complement-mediated immune complex handling, and the extent of complement activation in untreated pulmonary tuberculosis compared to treated pulmonary tuberculosis patients and healthy controls. RESULTS: High immune complex levels, decreased complement-mediated solubilization, and increased activation of the complement system were observed in untreated tuberculosis patients. CONCLUSIONS: The results obtained from the present study suggest that complement mediated solubilization is less in patients with tuberculosis, and this defective solubilization is likely to take part in a vicious cycle involving immune complex deposition and complement activation and, thus, may lead to disease progression depending on the nature of the defect.


Subject(s)
Antigen-Antibody Complex/biosynthesis , Complement C3/metabolism , Complement C4/metabolism , Mycobacterium tuberculosis/immunology , Tuberculosis, Pulmonary/immunology , Adult , Antigen-Antibody Complex/blood , Antigen-Antibody Complex/genetics , Biomarkers/blood , Complement Activation/genetics , Complement C3/genetics , Complement C3/immunology , Complement C4/genetics , Complement C4/immunology , Cytotoxicity, Immunologic , Female , Humans , Immune Complex Diseases/congenital , Male , Middle Aged , Monitoring, Immunologic , Mycobacterium tuberculosis/pathogenicity , Prognosis , Tuberculosis, Pulmonary/blood , Tuberculosis, Pulmonary/diagnosis , Tuberculosis, Pulmonary/genetics , Tuberculosis, Pulmonary/physiopathology , Virulence
18.
PLoS One ; 3(12): e3869, 2008.
Article in English | MEDLINE | ID: mdl-19052643

ABSTRACT

BACKGROUND: The variable efficacy (0-80%) of Mycobacterium bovis Bacille Calmette Guréin (BCG) vaccine against adult tuberculosis (TB) necessitates development of alternative vaccine candidates. Development of recombinant BCG (rBCG) over-expressing promising immunodominant antigens of M. tuberculosis represents one of the potential approaches for the development of vaccines against TB. METHODS/PRINCIPAL FINDINGS: A recombinant strain of BCG - rBCG85C, over expressing the antigen 85C, a secretory immuno-dominant protein of M. tuberculosis, was evaluated for its protective efficacy in guinea pigs against M. tuberculosis challenge by aerosol route. Immunization with rBCG85C resulted in a substantial reduction in the lung (1.87 log(10), p<0.01) and spleen (2.36 log(10), p<0.001) bacillary load with a commensurate reduction in pathological damage, when compared to the animals immunized with the parent BCG strain at 10 weeks post-infection. rBCG85C continued to provide superior protection over BCG even when post-challenge period was prolonged to 16 weeks. The cytokine profile of pulmonary granulomas revealed that the superior protection imparted by rBCG85C was associated with the reduced levels of pro-inflammatory cytokines - interleukin (IL)-12, interferon (IFN)-gamma, tumor necrosis factor (TNF)-alpha, moderate levels of anti-inflammatory cytokine - transforming growth factor (TGF)-beta along with up-regulation of inducible nitric oxide synthase (iNOS). In addition, the rBCG85C vaccine induced modulation of the cytokine levels was found to be associated with reduced fibrosis and antigen load accompanied by the restoration of normal lung architecture. CONCLUSIONS/SIGNIFICANCE: These results clearly indicate the superiority of rBCG85C over BCG as a promising prophylactic vaccine against TB. The enduring protection observed in this study gives enough reason to postulate that if an open-ended study is carried out with low dose of infection, rBCG85C vaccine in all likelihood would show enhanced survival of guinea pigs.


Subject(s)
BCG Vaccine , Cytokines/metabolism , Lung/immunology , Tuberculosis/prevention & control , Animals , BCG Vaccine/genetics , BCG Vaccine/immunology , Female , Guinea Pigs , Immunohistochemistry , Lung/microbiology , Mycobacterium bovis/immunology , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/immunology , Tuberculosis/immunology
19.
Clin Immunol ; 128(1): 109-15, 2008 Jul.
Article in English | MEDLINE | ID: mdl-18434253

ABSTRACT

Complement receptor 1 expressed on erythrocytes is involved in the transport of circulating immune complexes from the circulation to the mononuclear phagocyte system for safe disposal. The prevalence of complement receptor 1 genotypes and the association between circulating immune complexes and expression of complement receptor 1 on erythrocytes in pulmonary tuberculosis are not fully understood. Observations from this study showed increased occurrence of HH genotype in patients with pulmonary tuberculosis. Patients with tuberculosis had decreased erythrocyte complement receptor 1 and increased immune complex levels compared to healthy controls which also correlated with increasing severity of the disease. In addition, the expression of complement receptor 1 on erythrocytes correlated inversely with the levels of circulating immune complexes. This study suggests that the presence of HH genotype is high in pulmonary tuberculosis patients and the reduced complement receptor 1 in patients may be an acquired phenomenon related to disease pathogenesis.


Subject(s)
Erythrocytes/metabolism , Receptors, Complement 3b/biosynthesis , Receptors, Complement 3b/genetics , Tuberculosis, Pulmonary/genetics , Tuberculosis, Pulmonary/metabolism , Adult , Antigen-Antibody Complex/blood , Enzyme-Linked Immunosorbent Assay , Female , Flow Cytometry , Genotype , Humans , Male , Polymerase Chain Reaction , Polymorphism, Genetic , Tuberculosis, Pulmonary/blood
SELECTION OF CITATIONS
SEARCH DETAIL
...